Investment House LLC’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Hold
1,155
0.01% 212
2026
Q1
$212K Sell
1,155
-575
-33% -$106K 0.01% 213
2025
Q4
$304K Hold
1,730
0.01% 185
2025
Q3
$242K Hold
1,730
0.01% 212
2025
Q2
$217K Sell
1,730
-1,489
-46% -$186K 0.01% 211
2025
Q1
$440K Sell
3,219
-50
-2% -$7.15K 0.03% 181
2024
Q4
$500K Hold
3,269
0.03% 162
2024
Q3
$634K Hold
3,269
0.03% 161
2024
Q2
$758K Hold
3,269
0.04% 140
2024
Q1
$705K Hold
3,269
0.04% 145
2023
Q4
$846K Sell
3,269
-67
-2% -$16.5K 0.06% 126
2023
Q3
$857K Buy
3,336
+100
+3% +$26.7K 0.07% 123
2023
Q2
$922K Sell
3,236
-424
-12% -$126K 0.07% 121
2023
Q1
$1.02M Hold
3,660
0.08% 114
2022
Q4
$1.01M Hold
3,660
0.09% 97
2022
Q3
$977K Sell
3,660
-55
-1% -$11.7K 0.09% 99
2022
Q2
$758K Sell
3,715
-272
-7% -$55.6K 0.07% 112
2022
Q1
$840K Sell
3,987
-115
-3% -$25K 0.06% 114
2021
Q4
$984K Sell
4,102
-100
-2% -$25.7K 0.06% 115
2021
Q3
$1.19M Hold
4,202
0.09% 107
2021
Q2
$1.46M Hold
4,202
0.1% 105
2021
Q1
$1.18M Sell
4,202
-1,215
-22% -$328K 0.09% 110
2020
Q4
$1.33M Sell
5,417
-1,022
-16% -$264K 0.09% 116
2020
Q3
$1.83M Sell
6,439
-75
-1% -$20.9K 0.14% 87
2020
Q2
$1.74M Sell
6,514
-75
-1% -$22.5K 0.15% 91
2020
Q1
$2.08M Sell
6,589
-263
-4% -$79.8K 0.24% 82
2019
Q4
$2.03M Sell
6,852
-148
-2% -$41.1K 0.19% 92
2019
Q3
$1.63M Sell
7,000
-1,528
-18% -$356K 0.16% 94
2019
Q2
$1.99M Buy
8,528
+1,431
+20% +$330K 0.21% 86
2019
Q1
$1.68M Sell
7,097
-55
-0.8% -$17.3K 0.18% 92
2018
Q4
$2.15M Sell
7,152
-3,568
-33% -$1.14M 0.27% 80
2018
Q3
$3.79M Sell
10,720
-476
-4% -$164K 0.4% 67
2018
Q2
$3.25M Buy
11,196
+186
+2% +$52.3K 0.38% 69
2018
Q1
$3.02M Sell
11,010
-5
-0% -$1.55K 0.37% 72
2017
Q4
$3.51M Sell
11,015
-682
-6% -$219K 0.43% 63
2017
Q3
$3.66M Hold
11,697
0.48% 65
2017
Q2
$3.17M Sell
11,697
-90
-0.8% -$23.8K 0.43% 68
2017
Q1
$3.22M Buy
11,787
+433
+4% +$122K 0.45% 69
2016
Q4
$3.22M Sell
11,354
-60
-0.5% -$17.8K 0.49% 69
2016
Q3
$3.57M Buy
11,414
+215
+2% +$63.7K 0.54% 61
2016
Q2
$2.71M Sell
11,199
-145
-1% -$38.2K 0.43% 75
2016
Q1
$2.95M Buy
11,344
+40
+0.4% +$10.6K 0.47% 71
2015
Q4
$3.46M Sell
11,304
-250
-2% -$71.8K 0.56% 63
2015
Q3
$3.37M Hold
11,554
0.59% 60
2015
Q2
$4.67M Sell
11,554
-52
-0.4% -$20.9K 0.75% 46
2015
Q1
$4.9M Sell
11,606
-395
-3% -$156K 0.79% 48
2014
Q4
$4.07M Sell
12,001
-200
-2% -$64.7K 0.66% 54
2014
Q3
$4.04M Sell
12,201
-435
-3% -$143K 0.67% 47
2014
Q2
$3.98M Sell
12,636
-67
-0.5% -$20.2K 0.68% 51
2014
Q1
$3.88M Hold
12,703
0.69% 51
2013
Q4
$3.55M Sell
12,703
-15
-0.1% -$3.88K 0.64% 54
2013
Q3
$3.06M Buy
12,718
+275
+2% +$61.5K 0.62% 62
2013
Q2
$2.68M Buy
+12,443
New +$2.66M 0.58% 65

Other funds holding BIIB

Investment House LLC's BIIB Position: Q2 2026 in Review

Investment House LLC held its Biogen (BIIB) position steady in Q2 2026 at 1,155 shares worth $250K. The position accounts for 0.01% of the portfolio, ranked #212.

Investment House LLC first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.9M in Q1 2015. 405 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Investment House LLC held 1,155 shares of Biogen worth $250K as of Q2 2026.
  • Investment House LLC left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.01% of Investment House LLC's portfolio in Q2 2026, its #212 holding.
  • Investment House LLC first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
  • Investment House LLC's Biogen position peaked at $4.9M in Q1 2015.
  • 405 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Investment House LLC's 13F filing for Q2 2026, filed 21 Jul 2026.